ESAB Reports Mixed Q1 2026: Sales Up, Margins Squeeze
Event summary
- ESAB reported Q1 2026 sales of $746M, up 10% year-over-year but down 1% on a core organic basis.
- Core adjusted EBITDA rose 6% to $136M, but margins contracted by 80 basis points to 19.0%.
- Conflict in Iran added costs, offset by pricing actions; EWM integration ahead of schedule.
- Eddyfi acquisition on track to close mid-2026; Brent Jones named new CFO.
- Full-year 2026 guidance reaffirmed: 6-9% core sales growth, $575M-$595M EBITDA.
The big picture
ESAB's Q1 results reflect the tension between top-line resilience and margin compression amid geopolitical disruptions. The company's push to become a 'premier industrial compounder' hinges on successful integration of recent acquisitions and sustained pricing power. With $746M in quarterly sales and a pipeline of strategic deals, ESAB's ability to navigate supply chain volatility will shape its trajectory in the industrial equipment sector.
What we're watching
- Geopolitical Pressures
- How Iran conflict costs will impact margins and whether pricing actions fully offset them.
- Integration Pace
- The speed at which EWM and Eddyfi integrations drive revenue synergies.
- Organic Growth
- Whether core organic sales growth can accelerate beyond the 2-4% guided range.
Related topics